Suppression of experimental colitis by intestinal mononuclear phagocytes

Journal of Leukocyte Biology

Volumn 80, Issue 4, 2006, Pages 802-815

  Qualls, Joseph E ^a   Kaplan, Alan M ^a   Van Rooijen, Nico ^b   Cohen, Donald A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Dendritic cells; Dextran sodium sulfate; Mice; Monocytes macrophages

Indexed keywords

CLODRONIC ACID; DEXTRAN SULFATE; FAS ANTIGEN; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; COLITIS; DENDRITIC CELL; DEPLETION; DISEASE SEVERITY; DOWN REGULATION; ENTERITIS; FECES; FEMALE; HISTOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; INTESTINE CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; CHEMOKINES, CXC; COLITIS; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; INTESTINES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; MICE, TRANSGENIC; NEUTROPHILS; PHAGOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

MUS MUSCULUS;

EID: 33751549013     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1205734     Document Type: Article

References (64)

1. Bouma, G., Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533.
2. Baron, S., Turck, D., Leplat, C., Merle, V., Gower-Rousseau, C., Marti, R., Yzet, T., Lerebours, E., Dupas, J. L., Debeugny, S., Salomez, J. L., Cortot, A., Colombel, J. F. (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population-based case control study. Gut 54, 357-363.
3. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
4. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
5. Schreiber, S., Rosenstiel, P., Albrecht, M., Hampe, J., Krawczak, M. (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat. Rev. Genet. 6, 376-388.
6. Sansonetti, P. J. (2004) War and peace at mucosal surfaces. Nat. Rev. Immunol. 4, 953-964.
7. Kitajima, S., Morimoto, M., Sagara, E., Shimizu, C., Ikeda, Y. (2001) Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp. Anim. 50, 387-395.
8. Strober, W., Fuss, I. J., Blumberg, R. S. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549.
9. Rembacken, B. J., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., Axon, A. T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 354, 635-639.
10. Sutherland, L., Singleton, J., Sessions, J., Hanauer, S., Krawitt, E., Rankin, G., Summers, R., Mekhjian, H., Greenberger, N., Kelly, M., et al. (1991) Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32, 1071-1075.
11. Turunen, U. M., Farkkila, M. A., Hakala, K., Seppala, K., Sivonen, A., Ogren, M., Vuoristo, M., Valtonen, V. V., Miettinen, T. A. (1998) Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 115, 1072-1078.
12. Laroux, F. S., Grisham, M. B. (2001) Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 8, 283-301.
13. Axelsson, L. G., Landstrom, E., Goldschmidt, T. J., Gronberg, A., Bylund-Fellenius, A. C. (1996) Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 45, 181-191.
14. Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P., Elson, C. O. (1994) Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652.
15. Watanabe, N., Ikuta, K., Okazaki, K., Nakase, H., Tabata, Y., Matsuura, M., Tamaki, H., Kawanami, C., Honjo, T., Chiba, T. (2003) Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig. Dis. Sci. 48, 408-414.
16. Autschbach, F., Giese, T., Gassler, N., Sido, B., Heuschen, G., Heuschen, U., Zuna, I., Schulz, P., Weckauf, H., Berger, I., Otto, H. F., Meuer, S. C. (2002) Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch. 441, 500-513.
17. Banks, C., Bateman, A., Payne, R., Johnson, P., Sheron, N. (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199, 28-35.
18. Rogler, G., Andus, T. (1998) Cytokines in inflammatory bowel disease. World J. Surg. 22, 382-389.
19. Garside, P. (1999) Cytokines in experimental colitis. Clin. Exp. Immunol. 118, 337-339.
20. Jurjus, A. R., Khoury, N. N., Reimund, J. M. (2004) Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50, 81-92.
21. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
22. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I., Stappenbeck, T. S. (2005) Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102, 99-104.
23. Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., Watanabe, M. (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23.
24. Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., Raz, E. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695-702.
25. Leithauser, F., Trobonjaca, Z., Moller, P., Reimann, J. (2001) Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab. Invest. 81, 1339-1349.
26. Malmstrom, V., Shipton, D., Singh, B., Al-Shamkhani, A., Puklavec, M. J., Barclay, A. N., Powrie, F. (2001) CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166, 6972-6981.
27. Foti, M., Granucci, F., Ricciardi-Castagnoli, P. (2004) A central role for tissue-resident dendritic cells in innate responses. Trends Immunol. 25, 650-654.
28. Granucci, F., Zanoni, I., Pavelka, N., Van Dommelen, S. L., Andoniou, C. E., Belardelli, F., Degli Esposti, M. A., Ricciardi-Castagnoli, P. (2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200, 287-295.
29. Nolan, K. F., Strong, V., Soler, D., Fairchild, P. J., Cobbold, S. P., Croxton, R., Gonzalo, J. A., Rubio, A., Wells, M., Waldmann, H. (2004) IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J. Immunol. 172, 2201-2209.
30. Burnett, S. H., Kershen, E. J., Zhang, J., Zeng, L., Straley, S. C., Kaplan, A. M., Cohen, D. A. (2004) Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75, 612-623.
31. Sasmono, R. T., Oceandy, D., Pollard, J. W., Tong, W., Pavli, P., Wainwright, B. J., Ostrowski, M. C., Himes, S. R., Hume, D. A. (2003) A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101, 1155-1163.
32. Thomis, D. C., Marktel, S., Bonini, C., Traversari, C., Gilman, M., Bordignon, C., Clackson, T. (2001) A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Blood 97, 1249-1257.
33. Murthy, S. N., Cooper, H. S., Shim, H., Shah, R. S., Ibrahim, S. A., Sedergran, D. J. (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722-1734.
34. Van Rooijen, N., Sanders, A. (1994) Liposome-mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93.
35. Berg, D. J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., Rennick, D. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98, 1010-1020.
36. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
37. Smith, P. D., Ochsenbauer-Jambor, C., Smythies, L. E. (2005) Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206, 149-159.
38. Smythies, L. E., Sellers, M., Clements, R. H., Mosteller-Barnum, M., Meng, G., Benjamin, W. H., Orenstein, J. M., Smith, P. D. (2005) Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75.
39. Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T., Scholmerich, J., Herfarth, H., Ray, K., Falk, W., Rogler, G. (2002) Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122, 1987-2000.
40. Duchmann, R., Neurath, M. F., Meyer zum Buschenfelde, K. H. (1997) Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Res. Immunol. 148, 589-594.
41. Autschbach, F., Braunstein, J., Helmke, B., Zuna, I., Schurmann, G., Niemir, Z. I., Wallich, R., Otto, H. F., Meuer, S. C. (1998) In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am. J. Pathol. 153, 121-130.
42. Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M., Moorghen, M. (1993) TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer 68, 137-139.
43. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
44. Shimizu, T., Cai, S., Tomioka, H. (2005) Roles of reactive nitrogen intermediates and transforming growth factor-β produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation. Cytokine 30, 7-13.
45. Bilsborough, J., Viney, J. L. (2004) Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127, 300-309.
46. Kelsall, B. L., Leon, F. (2005) Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol. Rev. 206, 132-148.
47. Stagg, A. J., Hart, A. L., Knight, S. C., Kamm, M. A. (2003) The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52, 1522-1529.
48. Uhlig, H. H., Powrie, F. (2003) Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J. Clin. Invest. 112, 648-651.
49. Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., Stagg, A. J. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50-65.
50. Iwasaki, A., Kelsall, B. L. (1999) Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239.
51. Crowther, M., Brown, N. J., Bishop, E. T., Lewis, C. E. (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70, 478-490.
52. DiPietro, L. A. (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4, 233-240.
53. Mutsaers, S. E., Whitaker, D., Papadimitriou, J. M. (2002) Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am. J. Pathol. 160, 681-692.
54. Park, J. E., Barbul, A. (2004) Understanding the role of immune regulation in wound healing. Am. J. Surg. 187, 11S-16S.
55. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R. (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
56. Fukata, M., Michelsen, K. S., Eri, R., Thomas, L. S., Hu, B., Lukasek, K., Nast, C. C., Lechago, J., Xu, R., Naiki, Y., Soliman, A., Arditi, M., Abreu, M. T. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055-G1065.
57. Xu, H., Manivannan, A., Dawson, R., Crane, I. J., Mack, M., Sharp, P., Liversidge, J. (2005) Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators. J. Immunol. 175, 6915-6923.
58. Sunderkotter, C., Nikolic, T., Dillon, M. J., Van Rooijen, N., Stehling, M., Drevets, D. A., Leenen, P. J. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172, 4410-4417.
59. Carlson, M., Raab, Y., Seveus, L., Xu, S., Hallgren, R., Venge, P. (2002) Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 50, 501-506.
60. Raab, Y., Gerdin, B., Ahlstedt, S., Hallgren, R. (1993) Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34, 1203-1206.
61. Song, F., Ito, K., Denning, T. L., Kuninger, D., Papaconstantinou, J., Gourley, W., Klimpel, G., Balish, E., Hokanson, J., Ernst, P. B. (1999) Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J. Immunol. 162, 2275-2280.
62. Thorpe, C. M., Smith, W. E., Hurley, B. P., Acheson, D. W. (2001) Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect. Immun. 69, 6140-6147.
63. Yang, S. K., Eckmann, L., Panja, A., Kagnoff, M. F. (1997) Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113, 1214-1223.
64. Dovi, J. V., He, L. K., DiPietro, L. A. (2003) Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 73, 448-455.